Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated April 29, 2026, titled "OneSource s Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection".
Press Release Apr 29 2026
Earlier from Onesource Specialty Pharma
- Press Release Apr 21 2026
- Press Release Feb 11 2026
- Press Release Nov 11 2025
- Inseego and National MSP OneSource Join Forces to Tackle the Growing 5G FWA Market Opportunity